Are New Ultra-Rapid-Acting Insulins Associated with Improved Glycemic Control and Reduced Hypoglycemia in Comparison to Conventional Rapid-Acting Insulins for Individuals with Type 1 and Type 2 Diabetes? A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Are New Ultra-Rapid-Acting Insulins Associated with Improved Glycemic Control and Reduced Hypoglycemia in Comparison to Conventional Rapid-Acting Insulins for Individuals with Type 1 and Type 2 Diabetes? A Systematic Review and Meta-Analysis

Published:2024-08-01 Issue:8 Volume:26 Page:575-586
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Villar-Taibo Rocío¹^ORCID,Galdón Sanz-Pastor Alba²³,Fernández-Rubio Elsa⁴⁵,Barajas Galindo David⁶^ORCID,Simó Servat Andreu⁷,Ampudia-Blasco Francisco Javier⁸⁹¹⁰¹¹

Affiliation:

1. Endocrinology Department, University Hospital of Santiago de Compostela, Neoplasia and Differentiation of Endocrine Cells Group, Instituto de Investigación Sanitaria—IDIS (Health Research Institute), Santiago de Compostela, Spain.

2. Department of Endocrinology and Nutrition, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

3. Medicine Department, Complutense University of Madrid, Madrid, Spain.

4. Department of Endocrinology and Nutrition, Cruces University Hospital, Barakaldo, Spain.

5. Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.

6. Section of Endocrinology and Nutrition, Complejo Asistencial Universitario de León, León, Spain.

7. Hospital Universitari Mutua Terrassa, Terrassa, Spain.

8. Department of Endocrinology and Nutrition, Hospital Clínico Universitario de Valencia, Valencia, Spain.

9. INCLIVA Research Foundation, Valencia, Spain.

10. CIBERDEM, Madrid, Spain.

11. Department of Medicine, Universitat de Valencia, Valencia, Spain.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2023.0524

Reference53 articles.

1. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

2. 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

3. How often patients on insulin therapy measure postprandial glycemia and modify insulin doses accordingly? From an on-line survey in insulin-treated diabetes patients in Spain

4. Postprandial Blood Glucose Is a Stronger Predictor of Cardiovascular Events Than Fasting Blood Glucose in Type 2 Diabetes Mellitus, Particularly in Women: Lessons from the San Luigi Gonzaga Diabetes Study